CeMines(R), Inc. today announced that the Company has been soliciting offers to purchase its Research Tools business and related inventory of polyclonal antibodies, cDNA and mRNA. The business also includes associated trademarks and an elite multinational customer base that includes some of the world’s most prestigious research institutions.
